Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Alto Neuroscience Inc.
IPO Date: February 2, 2024
Sector: Healthcare
Industry: Biotech
Market Cap: $99.37M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.32 | 3.95%
Avg Daily Range (30 D): $0.10 | 2.86%
Avg Daily Range (90 D): $0.09 | 3.39%
Institutional Daily Volume
Avg Daily Volume: .27M
Avg Daily Volume (30 D): .09M
Avg Daily Volume (90 D): .15M
Trade Size
Avg Trade Size (Sh.): 106
Avg Trade Size (Sh.) (30 D): 122
Avg Trade Size (Sh.) (90 D): 121
Institutional Trades
Total Inst.Trades: 68
Avg Inst. Trade: $1.64M
Avg Inst. Trade (30 D): $1.67M
Avg Inst. Trade (90 D): $1.39M
Avg Inst. Trade Volume: .17M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $3.17M
Avg Closing Trade (30 D): $3.88M
Avg Closing Trade (90 D): $3.88M
Avg Closing Volume: 323.58K
   
News
Sep 5, 2025 @ 4:30 PM
ANRO DEADLINE: ROSEN, GLOBAL INVESTOR RIGHTS COUNS...
Source: Rosen Law Firm
Sep 3, 2025 @ 5:00 PM
PDE4B Inhibitor Market Poised for Strong Growth by...
Source: Delveinsight
Sep 3, 2025 @ 3:36 AM
ANRO DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Enc...
Source: Rosen Law Firm
Sep 2, 2025 @ 7:55 PM
Levi & Korsinsky Reminds Shareholders of a Lead Pl...
Source: Levi & Korsinsky, Llp
Sep 1, 2025 @ 8:00 PM
ANRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman...
Source: Bronstein, Gewirtz & Grossman Llc
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-2.34 $-.56 $-.56
Diluted EPS $-2.34 $-.56 $-.56
Revenue $ M $ M $ M
Gross Profit $ $ $
Net Income / Loss $ -63.18M $ -15.17M $ -15.2M
Operating Income / Loss $ -69.9M $ -15.68M $ -17M
Cost of Revenue $ $ $
Net Cash Flow $ -44.64M $ -7.48M $ -13.47M
PE Ratio